Conclusion  Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples.
Trial Registration  clinicaltrials.gov Identifier: NCT00447564 (Source: JAMA)